Here's Why You Should Hold Onto Chemours (CC) Stock Now
Zacks Investment Research | Mar 24, 2020 11:14PM ET
The Chemours Company (NYSE:CC) is poised to benefit from increasing adoption of its Opteon platform and its productivity actions amid certain challenges including illegal imports of refrigerants.
Shares of this chemical maker are down 73.8% over a year, compared with the 56.6% decline of its industry .
Let’s find out why this Zacks Rank #3 (Hold) stock is worth retaining at the moment.
What’s Working in CC’s Favor?
Chemours is benefiting from continued customer adoption of Opteon refrigerants. It is seeing strong adoption of Opteon for mobile applications. Chemours remains committed to drive Opteon adoption. It expects sustained adoption in the automotive segment this year. The company will also continue to ramp up the new low-cost Corpus Christi Opteon facility in Texas in 2020. The facility has tripled the company’s Opteon capacity allowing it to meet future demand.
The company also stands to gain from its actions to manage costs and drive productivity. Its productivity and operational improvement actions across its businesses are expected to support margins in 2020. For 2020, Chemours projects adjusted EBITDA of $1.05-$1.25 billion, up 13% year over year at the midpoint, factoring in the benefits of its productivity actions and improved operating performance.
The company also remains committed to return value to shareholders leveraging healthy cash flows. It generated strong free cash flow of $304 million in the last reported quarter, a nearly three-fold year-over-year increase. Chemours also returned $486 million to its shareholders in 2019.
Chemours expects to generate free cash flow of more than $350 million in 2020, more than doubling from $169 million in 2019, driven by lower capital spending. The company expects to use a significant portion of this to drive shareholder value this year.
Headwinds Remain
Chemours is facing headwinds from illegal imports of HFC (hydrochlorofluorocarbon) refrigerants into the European Union from China, which is hurting sales and margins in its Fluoroproducts segment. These illegal imports are hurting pricing and volumes of refrigerants. The headwind is expected to continue over the near term. Weakness in global automotive and electronics markets is also likely to affect volumes in the Fluoroproducts unit.
Get The News You Want
Moreover, Chemours is seeing pressure on Ti-Pure TiO2 (titanium dioxide) pigment volumes. The company witnessed lower volumes for these products during 2019 due to customer destocking. Softness is likely to sustain in the first quarter of 2020 amid a still challenging market environment. Weaker volumes are likely to continue to impact sales of the Titanium Technologies segment in the first quarter.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.